Low strength Esomezole Plus Tab priced same as Eso Duo

By Lee, Tak-Sun | translator Alice Kang

22.06.28 06:18:16

가나다라 0

Hanmi sets the ceiling price of its low-strength drug the same as Chong Kun Dang’s Eso Duo in line with its higher-strength drug

The two companies are in heated competition to take or maintain their ‘No.1’ position in the ‘PPI+antacid combo’ market… each company’s pride in their sales power in line

Hanmi Pharmaceutical has decided to set the ceiling price of its gastroesophageal reflux disease (GERD) treatment combo ‘Esomezole Plus (esomeprazole+ magnesium hydroxide)’ at the same level as Chong Kun Dang’s ‘Eso Duo (esomeprazole+sodium bicarbonate)’ to directly target Eso Duo in the market.

Its lower strength formulation, in addition to its higher strength, is setting out to the market at the same price as Chong Kun Dang’s Eso Duo.

According to the Ministry of Health and Welfare, Esomezole Plus 20/350mg Tab will be listed for insurance benefit at a ceiling price of ₩720 from the 1st of next month.

This is the same price as Eso Duo 20/800mg Tab. Both produc

Lee, Tak-Sun(hooggasi2@dailypharm.com)

If you want to see the full article, please JOIN US (click)